Pharmaceuticals News & Press Release Distribution

Pharmaceuticals

APAC
Global

China SXT Pharmaceuticals, Inc. Being Admitted to Hi-tech Zone of Huangshan City in Anhui Province

TAIZHOU, China, May 22, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced today the laun...

2019-05-22 23:20 6991

Scientists Identify New Therapeutic Target for Fatty Liver Disease

* Preclinical study highlights a novel therapy for the treatment of fatty liver disease, which affects up to 25% of the global population * Inhibiting interleukin 11 (IL11) signalling addresses multiple aspects of non-alcoholic steatohepatitis (NASH), including hepatic inflammation and fibros...

2019-05-22 18:24 1960

FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis

ADELAIDE, Australia, May 22, 2019 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved SORILUX® (calcipotriene) Foam, 0.005% in adolescents. SORILUX is now approved for treating plaque psoriasis of the scalp and b...

2019-05-22 18:00 6571

Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial

Subjects dosed in First-in-Human study of INO-4500 funded by the Coalition for Epidemic Preparedness Innovations Planned for emergency use as a stockpiled vaccine PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, ...

2019-05-21 21:00 3912

First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA

* Racemic sublingual ketamine, Wafermine, is the first sublingual ketamine drug seeking FDA approval for the treatment of moderate to severe acute pain * Wafermine is a Phase 2-ready drug for treatment resistant depression SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C) anno...

2019-05-21 18:11 11153

Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

- TRANSVAC2, part of the EU's Horizon 2020 program, provides trainings to streamline vaccine manufacturing and development - Merck to offer its M Lab™ Collaboration Center in Molsheim, France for process development skills training DARMSTADT, Germany, May 20, 2019 /PRNewswire/ -- Merck, a leadin...

2019-05-20 20:00 2968

Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

SYDNEY, May 20, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a US-based cance...

2019-05-20 11:41 4131

Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea and DALLAS, May 20, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical-stage biotech company developing novel therapeutics for areas with high unmet medical needs, announced that the company presented interim data from a Phase I clinical study on BBT-877, a drug c...

2019-05-20 08:38 1812

Chairman and Managing Director of AMN Life Science Honored at the 10th Asia Pacific Entrepreneurship Awards 2019

NEW DELHI, May 17, 2019 /PRNewswire/ -- With the theme of 'Promoting Inclusive Economic Development Through Sustainable Entrepreneurship',15 top entrepreneurs and enterprises were recognized at the Asia Pacific Entrepreneurship Awards (APEA) 2019 held at Hotel Andaz Delhi Aerocity,India on 18 Apr...

2019-05-17 16:52 2508

Chairman and Managing Director of AMN Life Science Honored at the 10th Asia Pacific Entrepreneurship Awards 2019

ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration

SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 16, 2019 /PRNewswire/ -- Shanghai ChemPartner a leading global Contract Research Organization (CRO), along withBerkeley Lights, Inc. (BLI) , the leader in digital cell biology, announced ...

2019-05-16 23:00 1775

Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure

CHENNAI, India, May 15, 2019 /PRNewswire/ -- In a first-ever milestone in cancer treatment inIndia, the Apollo Proton Cancer Center (APCC) in Chennai has successfully performed Total Marrow Irradiation (TMI) as a conditioning protocol prior to Bone Marrow Transplant.

2019-05-15 22:46 2377

Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure

Hangzhou attracts RMB1.5 billion investments in bio-pharmaceutical projects in Q1

HANGZHOU, China, May 15, 2019 /PRNewswire/ -- Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of1.5 billion yuan, according to the latest data of the Hangzhou Investment Promotion...

2019-05-15 20:56 3151

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

SYDNEY, May 15, 2019 /PRNewswire/ -- NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in t...

2019-05-15 20:13 1899

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results

HAIKOU, China, May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...

2019-05-15 18:00 8359

Ping An Good Doctor and Wyeth Reached Strategic Cooperation

SHANGHAI, May 15, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK) announced strategic cooperation with Wyeth Nutrition on15 May 2019. Both sides will utilize their strengths in their respective fields for an all...

2019-05-15 15:20 5873

FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

DARMSTADT, Germany and NEW YORK, May 15, 2019 /PRNewswire/ -- Not intended for US, Canada and UK-based media * BAVENCIO is the first anti-PD-L1 in combination with axitinib approved by FDA for first-line treatment of patients with advanced renal cell carcinoma (RCC) * Phase III study show...

2019-05-15 08:25 3589

Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership

BOONE, North Carolina, May 15, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodi...

2019-05-15 07:53 2281

Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business

LEXINGTON, Massachusetts, May 15, 2019 /PRNewswire/ -- Sekisui Diagnostics Enzyme business announces the completion of a newBioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a$1.9 million investment. This investment is part of a long-term investment strateg...

2019-05-15 03:11 2230

Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business

Peritech Pharma Granted Patents for China and Russia

HERZLIYA, Israel, May 14, 2019 /PRNewswire/ -- Peritech Pharma , a specialty anal-rectal pharmaceutical company, today announced it has been granted patents coveringChina and Russia for its drug delivery platform used for two of its over-the-counter products, PP-110 f...

2019-05-14 08:55 3183

Frost & Sullivan Publishes Annual Update on BioLineRx

TEL AVIV, Israel, May 13, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure o...

2019-05-13 23:46 1186

1 ... 290 291 292293294